(Q34568677)

English

Growth suppression of human hepatocellular carcinoma xenografts by a monoclonal antibody CH12 directed to epidermal growth factor receptor variant III

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Growth suppression of human hepatocellular carcinoma xenografts by a monoclonal antibody CH12 directed to epidermal growth factor receptor variant III (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

author name string

Hua Jiang

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Huamao Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Zhonghua Tan

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Suwen Hu

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Hai Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Bizhi Shi

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Lin Yang

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Peiyong Li

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Jianren Gu

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Hongyang Wang

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Zonghai Li

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

16 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

286

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

5913-5920

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

describes a project that uses

monoclonal antibody

1 reference

based on heuristic

inferred from title

Evolving strategies for the treatment of hepatocellular carcinoma: from clinical-guided to molecularly-tailored therapeutic options.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

Identification and characterization of Ch806 mimotopes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

Targeted drugs in metastatic colorectal cancer with special emphasis on guidelines for the use of bevacizumab and cetuximab: an Acta Oncologica expert report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

Epidermal growth factor receptor inhibition strategies in oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

Hepatocellular carcinoma: current management and future trends.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

Hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

Expression of constitutively activated EGFRvIII in non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

EGF mutant receptor vIII as a molecular target in cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

7 July 2018

Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110.192252

21 January 2018

Epidermal growth factor receptors (EGFR): a new target for anticancer therapy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110.192252

21 January 2018

Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110.192252

21 January 2018

Roles of EGFR-Stat3 signal pathway in carcinogenesis of experimental hepatoma in rats.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110.192252

21 January 2018

Expression and role of Bcl-xL in human hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110.192252

21 January 2018

Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037704

27 October 2018

[Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21163950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21163950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21163950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/21163950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carcinogen-induced alteration in liver epidermal growth factor receptor distribution during the promotion stage of hepatocarcinogenesis in rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/21163950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of transforming growth factor alpha and epidermal growth factor receptor in human hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21163950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence

1 reference

https://pubmed.ncbi.nlm.nih.gov/21163950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Expression and significance of epidermal growth factor receptor variant type III in hepatocellular carcinoma]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21163950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFRvIII mRNA detection in the serum of patients with hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21163950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21163950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21163950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of Bcl-xL in human hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21163950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1074/JBC.M110.192252

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34568677&oldid=1981046867"